A transport structure for accommodating a plurality of vials for pharmaceutical, medical or cosmetic use under non-sterile conditions is formed by an accommodation member and by a bearing member releasably connected thereto. The accommodation member comprises a plurality of frustro-conical receptacles in a regular arrangement so that the vials can be accommodated upright and while preventing a direct contact between adjacent vials in the receptacles of the accommodation member. The transport structure comprises latching structures for releasable latching of the accommodation member with the bearing member. According to the disclosure, the receptacles are matched to the height of the vials in such a manner that the vials can be completely accommodated therein, wherein the bearing member is formed by a base plate having a flat supporting surface facing the receptacles, so that the vials can be freely displaced on the supporting surface of the base plate after releasing the latching and can be pushed from the bearing member by displacement of the accommodation member relative to the bearing member. The accommodation member and/or the bearing member can be formed in one piece by thermoforming a plastic material, in particular by deep-drawing a thin film or a thin film plate.

Provided herein, in some embodiments, are rapid diagnostic tests to detect one or more target nucleic acid sequences (e.g., a nucleic acid sequence of one or more pathogens). In some embodiments, the pathogens are viral, bacterial, fungal, parasitic, or protozoan pathogens, such as SARS-CoV-2 or an influenza virus. Further embodiments provide methods of detecting genetic abnormalities. Diagnostic tests comprising a sample-collecting component, one or more reagents (e.g., lysis reagents, nucleic acid amplification reagents), and a detection component (e.g., a component comprising a lateral flow assay strip) are provided.

The invention relates to a capsule for use in a vaporizer, having at least one first cavity formed at least in part by a lid, side walls and bottom of the capsule, and a vaporizable active substance accommodated in the first cavity of the capsule, wherein the side walls and/or the bottom are at least in sections double-walled with an inner wall facing the first cavity of the capsule and an outer wall facing the outside of the capsule, so that at least one second cavity is formed between the inner wall and the outer wall of the capsule, inner wall facing the first cavity of the capsule and an outer wall facing the outside of the capsule, so that at least one second cavity is formed between the inner wall and the outer wall, wherein an auxiliary substance, preferably a further active substance, a chemical reactant and/or a flavoring agent is accommodated in the second cavity. A corresponding vaporizer as well as a corresponding vaporizer system are further described.

The invention relates to a device for tabletting a powdered, liquid, pasty, encapsulated or granular active ingredient composition, having a magazine which has a plurality of active ingredient containers each with an individually controllable dosing device and a nozzle for the active ingredient outlet, wherein the magazine is adjustable between a plurality of setting positions relative to at least one die chamber, wherein in each of the setting positions at least one of the nozzles faces an opening of the die chamber. A corresponding method is further described.

A cartridge comprising a cartridge body and a capture medium holder disposed within the body, the capture medium holder comprising a platform configured to receive a capture medium, the capture medium holder being configured to move relative to the cartridge body between a sample collection position in which the platform is aligned with a sample inlet of the cartridge body and an inspection position in which the platform is aligned with an inspection window of the cartridge body.

The present invention relates to a kit comprising: a) a bag having an outlet, the outlet being closable and openable; b) a solid and/or liquid active agent precursor; and c) means for releasing a gaseous active agent or a gaseous active agent mixture from the active agent precursor; a method for producing a gaseous active agent or a gaseous active agent mixture comprising the steps: a) providing the kit; b) providing the solid and/or liquid active ingredient precursor in the bag; and c) releasing the gaseous active ingredient or the gaseous active ingredient mixture from the solid and/or liquid active ingredient precursor with the aid of the means for releasing a gaseous active ingredient or a gaseous active ingredient mixture, and a gaseous composition obtainable by the process.

A glass container is provided that includes a tube, a circular bottom, and a longitudinal axis. A curved glass heel extends from an outer end the bottom to the first end of the tube. The two-dimensional distance h(x,y) between a contact plane and the outer surface. The two-dimensional distance is measured in a direction parallel to the axis. The slope magnitude of the outer surface at the given position x,y is given by

√{square root over ((dh/dx).sup.2+(dh/dy).sup.2)}.

The 75% quantile of values that have been determined for the term

√{square root over ((dh/dx).sup.2+(dh/dy).sup.2)}×d1/h(xy).sub.delta

for all given positions x,y within a circular area having a radius of 0.4×d2/2 and that correspond to the centre is less than 4100 μm/mm. The adjacent positions x,y increase stepwise by 200 μm, and h(x,y).sub.delta=h(x,y).sub.max−h(x,y).sub.min, h(x,y).sub.max is a maximum value for h(x,y) and h(x,y).sub.min is a minimum value for h(x,y) being determined in that circular area.

A glass container is provided that includes a tube, a circular bottom, and a longitudinal axis. A curved glass heel extends from an outer end the bottom to the first end of the tube. The outer surface has a topography defined by a function ĥ(x) that is an azimuthal average of a distance between a contact plane and the outer surface at any given position located on a circle having the centre and the radius |x|. The values ĥ for ĥ(x) are determined for a plurality of circles the radius of which increases stepwise by 500 μm starting with a circle around the centre having a radius of 500 μm. The values ĥ are determined in a range from x=−0.4×d2/2 to x=+0.4×d2/2, d2 having a size such that at least 4 values ĥ are determined and can be fitted with a curvature function

[00001]$\hat{h}\left(x\right)=\frac{-c\times x^2}{1+\sqrt{1-c^2\times x^2}}+h_0.$

A process for preparing a glass container that includes: providing a glass tube with a first portion, a second portion, and a longitudinal axis (L.sub.tube); holding the first portion in a first clamping chuck and the second portion in a second clamping chuck; rotating the glass tube around the longitudinal axis (L.sub.tube); heating, via a heater, the glass tube above a glass transition temperature; separating the first and second portions from one another by pulling apart along the longitudinal axis (L.sub.tube) while the heated glass tube is still rotating by moving the first and the second chucks away from each other; and moving the heater, while moving the first and second chucks away from each other, so that the heater follows a mass that remains at a circular end region of the first and/or second portion.

The present disclosure provides a set of spiked matrix standards comprising: one or more carriers, each carrier comprising: (a) a reference standard analyte in an amount that is different in each carrier; and (b) a blank matrix that is in admixture or in contact with the reference standard analyte. Methods for preparing and quantitating an analyte in a test sample comprises (a) providing one or more test samples to be tested for the presence of the analyte (b) providing a set of spiked matrix standards; (c) processing the standards and test samples and (d) quantitating the amount of analyte in each of the standards and test samples.